消息
Nordex (NDX1.DE) is a company that stands out from loss‑making businesses, as it has both revenues and profits. The company's strong earnings per share (EPS) growth is an indicator of solid profits, with EPS increasing from €0.13 to €1.35 in just one year. This breakout improvement in EPS is an attractive feature for investors.
12/06/2026 | Nordex SE
Overall, Intesa Sanpaolo’s valuation profile appears stable but carries risks tied to macro‑economic shifts, regulatory developments, and asset‑quality dynamics. The stock’s lower P/E and undervaluation relative to peers remain attractive, while market sentiment swings and sector sentiment shifts continue to influence share price trajectories.
12/06/2026 | Intesa Sanpaolo S.p.A.
The stock has fallen about 4.5 % in the last month, trading at €5.595 with a P/E of 10.3x—below the European banks’ average of 11.2x and the peer group average. Over the past three months the share has risen 7.3 % and has returned roughly 22.4 % in the past year. A discounted‑cash‑flow model values the share at €6.37, suggesting a discount relative...
12/06/2026 | Intesa Sanpaolo S.p.A.
Intesa Sanpaolo’s (ISP.MI) market assessment remains largely unchanged. Simply Wall St reports that analyst price targets and fair‑value estimates have not been revised; revenue growth, net‑profit margin, P/E ratio and discount rate inputs stay the same, implying that current expectations for performance are steady. The firm remains under scrutiny...
12/06/2026 | Intesa Sanpaolo S.p.A.
Chewy’s financial performance remains strong, with growth in net sales, margin expansion, and free cash flow, but the company faces challenges from a tougher consumer environment and the integration of a broader veterinary network. Its guidance reflects a more conservative view of growth, while ongoing investments in health‑care, private‑brand pene...
12/06/2026 | Chewy, Inc.
Analyst coverage has become more cautious. MoffettNathanson downgraded Chewy to neutral, cut its price target to $22 from $50, lowered the fiscal‑2026 revenue estimate to $13.43 billion from $13.63 billion, and trimmed the EPS forecast to $0.86 from $0.92. UBS reduced its target to $24 from $32, maintaining a neutral rating. Deutsche Bank cut its t...
12/06/2026 | Chewy, Inc.
Investor sentiment has cooled. The stock is down 43 % year‑to‑date and 84 % from COVID‑19 highs, trading at $19.92 (down from $20.42 before earnings). The Zacks Rank is #4 (Sell) and analysts have cut price targets, citing elevated fuel prices, macro‑economic pressure, and war‑related uncertainty. Jim Cramer labeled the stock a “hurt‑by‑war story”...
12/06/2026 | Chewy, Inc.
Chewy completed its acquisition of Modern Animal, expanding its Chewy Vet Care network. The acquisition connects physical clinics with an online pharmacy and AI‑powered pet‑health services. Chewy plans to operate 60 veterinary clinics by year‑end and expects AI‑driven savings of approximately $50 million next year, offsetting the added fixed costs...
12/06/2026 | Chewy, Inc.
Chewy updated its fiscal 2026 outlook: full‑year net sales expected $13.40 – $13.55 billion (down from $13.55 – $13.75 billion) and adjusted EBITDA margin guidance remains 6.6 – 6.8 %. Second‑quarter sales guidance is $3.30 – $3.33 billion. Management maintained the adjusted EBITDA margin target of 6.6 – 6.8 % despite a softer consumer backdrop, em...
12/06/2026 | Chewy, Inc.
Chewy, Inc. (NYSE: CHWY) reported first‑quarter fiscal 2026 results for the quarter ended May 3 2026. Net sales rose 7.7 % YoY to $3.36 billion, with gross margin expanding 50 basis points to 30.1 %. Net income reached $94.8 million, and adjusted EBITDA grew 31.3 % to $253.1 million, giving an adjusted EBITDA margin of 7.5 %. Active customers incre...
12/06/2026 | Chewy, Inc.